What is it about?
Dramatic regional variations in outcomes for patients with less survivable cancer (lung, pancreatic, brain, oesophageal and gastric) have been highlighted in a report published by MSD. This editorial examines this report and considers the implications for UK cancer strategy.
Photo by National Cancer Institute on Unsplash
Why is it important?
Over 90,000 people a year are diagnosed with less survivable cancers, accounting for 25% of new diagnoses and over 40% of deaths. It has been estimated that if the gaps between the best and worst performing regions were closed, more than 13000 deaths from less survivable cancer could be prevented each year.
Read the Original
This page is a summary of: Time to level up treatment for less survivable cancers, British Journal of Hospital Medicine, April 2023, Mark Allen Group, DOI: 10.12968/hmed.2023.0073.
You can read the full text:
The following have contributed to this page